Identification of recurrent regulated alternative splicing events across human solid tumors

Miri Danan-Gotthold, Regina Golan-Gerstl, Eli Eisenberg, Keren Meir, Rotem Karni*, Erez Y. Levanon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

117 Scopus citations


Cancer is a complex disease that involves aberrant gene expression regulation. Discriminating the modified expression patterns driving tumor biology from the many that have no or little contribution is important for understanding cancer molecular basis. Recurrent deregulation patterns observed in multiple cancer types are enriched for such driver events. Here, we studied splicing alterations in hundreds of matched tumor and normal RNA-seq samples of eight solid cancer types. We found hundreds of cassette exons for which splicing was altered in multiple cancer types and identified a set of highly frequent altered splicing events. Specific splicing regulators, including RBFOX2, MBNL1/2 and QKI, appear to account for many splicing alteration events in multiple cancer types. Together, our results provide a first global analysis of regulated splicing alterations in cancer and identify common events with a potential causative role in solid tumor development.

Original languageAmerican English
Pages (from-to)5130-5144
Number of pages15
JournalNucleic Acids Research
Issue number10
StatePublished - 2 Mar 2015

Bibliographical note

Publisher Copyright:
© 2015 The Author(s). Published by Oxford University Press on behalf of Nucleic Acids Research.


Dive into the research topics of 'Identification of recurrent regulated alternative splicing events across human solid tumors'. Together they form a unique fingerprint.

Cite this